Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Bayer Schering Pharma AG (BYERF.PK)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: BYERF.PK
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
December's Game Plan for Biotech
Dec 1
•
Justin M. Hall
•
4 Comments
Spectrum Pharma: Zevalin Sales Ramp Up
Nov 22
•
Justin M. Hall
•
23 Comments
Spectrum Pharma: Zevalin Has Blockbuster Potential
Oct 25
•
Justin M. Hall
•
36 Comments
Onyx Pharmaceuticals: Nexavar Promising for Metastatic Breast Cancer
Sep 23
•
Prohost Biotech
•
1 Comment
Onyx Pharmaceuticals: Is Nexavar the Next Avastin?
Sep 22
•
Raymond Chung
•
5 Comments
Report from Europe: Setting Up a Down Day for the Dow?
Sep 21
•
The Mole
•
2 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11
•
Justin M. Hall
•
23 Comments
Prices, Profits and the Economics of Big Pharma
Sep 9
•
Rortybomb
•
Comment!
Several Promising Deals for Biotech
Aug 30
•
The Burrill Report
•
1 Comment
Spectrum Pharmaceuticals: The Labor Day Catalyst
Aug 20
•
Justin M. Hall
•
18 Comments
Shorts on BASF Rose This Week
Aug 11
•
Data Explorers
•
Comment!
Spectrum Pharmaceuticals: Rumors of Buyout Talks Persist
Aug 10
•
Justin M. Hall
•
24 Comments
Goldilocks of Goldman, Market Bears and Positions for This Market
Aug 7
•
Global Investing Editor
•
7 Comments
Who Will Buy Spectrum Pharmacueticals?
Aug 6
•
Mark Cifra
•
2 Comments
Bayer Patent on Yasmin Affirmed Invalid
Aug 6
•
Aaron F. Barkoff
•
Comment!
These Small Cap Cancer Drugmakers Have Big Growth Potential
Aug 4
•
Justin M. Hall
•
24 Comments
Spectrum Pharmaceuticals: Potential Acquisition Target
Aug 2
•
Justin M. Hall
•
4 Comments
Renewable Gray Water - Sustainable Investments
Jul 20
•
James Rickman
•
4 Comments
Bright Prospects for Micromet (Part 1)
Apr 24
•
Ohad Hammer
•
Comment!
Winning Stocks in the Age of Personalized Medicine
Mar 4
•
John Putnam
•
Comment!
Failure to Launch for Last Year's Big Pharma and Biotech Hopes
Feb 13
•
EP Vantage
•
Comment!
Licensing Deal Is Imminent for ArQule
Oct 2, 2008
•
Ohad Hammer
•
6 Comments
14 Top Foreign Chemical Stocks With Stable Growth
Sep 22, 2008
•
David Hunkar
•
2 Comments
A Delay and a Deal for Pfizer
Sep 10, 2008
•
Mike Huckman
•
2 Comments
China Biotech in Review: A Week of Collaborations
Jun 29, 2008
•
ChinaBio Today
•
Comment!
Oculus to Use Bayer for Approval of Wound Treatment in Animals
Jun 25, 2008
•
ChinaBio Today
•
Comment!
Will Bayer AG Overtake AstraZeneca in China Drug Sales?
Jun 24, 2008
•
ChinaBio Today
•
Comment!
FDA Closer to Approval of EPIX's Vasovist
Jul 2, 2007
•
Douglas Goldstein
•
Comment!